Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Exploration of Potent Human α‐Glucosidase Inhibitors Using In Silico Approaches: Molecular Docking, DFT, Molecular Dynamics Simulations, and MMPBSA.

Autor: Bashyal, Jyoti¹ (AUTHOR), Raut, Bimal Kumar¹ (AUTHOR), Upadhyaya, Siddha Raj¹ (AUTHOR), Sharma, Kabita¹ (AUTHOR), Parajuli, Niranjan¹ (AUTHOR) niranjan.parajuli@cdc.tu.edu.np, Rajkhowa, Sanchayita¹ (AUTHOR)

Publikováno v: Journal of Chemistry. 9/14/2024, Vol. 2024, p1-16. 16p.

Chronic interleukin-2 treatment in awake sheep causes minimal or no injury to the lung microvascular barrier

Autor: D. Douguet, Neuburger M, Norman C. Staub, G. J. Jesmok, D. Lei, C. W. Johnson, E. H. Jerome, K. Enzan

Publikováno v: Journal of Applied Physiology. 81:1730-1738

Jerome, E. Heidi, Keiji Enzan, Dominique Douguet, Dachuan Lei, Gary Jesmok, Carol W. Johnson, Maritza Neuburger, and Norman C. Staub. Chronic interleukin-2 treatment in awake sheep causes minimal or no injury to the lung microvascular barrier. J. App

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061878a126ba40c51fb878b9ffe3eef1
https://doi.org/10.1152/jappl.1996.81.4.1730

Effects of interleukin-2 on the pulmonary microvasculature in anesthetized sheep

Autor: Norman C. Staub, D. Lei, C. W. Johnson, D. Douguet, G. J. Jesmok, E. H. Jerome, D. P. Schuster

Publikováno v: Journal of Applied Physiology. 76:909-915

Interleukin-2 (IL-2) is reputed to cause pulmonary microvascular injury. We studied the pulmonary and splanchnic microcirculation of anesthetized sheep after one dose (1.8 x 10(6) IU/kg) of IL-2 (n = 9) and after six doses (1.8 x 10(6) IU.kg-1.dose-1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b83e6893f17ef37bff697cd3f88a2f79
https://doi.org/10.1152/jappl.1994.76.2.909

Shock II

Autor: G. J. Wolbink, J. W. Baars, J. Wagstaff, A. Eerenberg, C. E. Hack, R. W. Faint, M. Mythen, I. J. Mackie, S. J. Machin, C. Routsi, S. Zakynthinos, B. Haviaras, A. Mavromatis, A. Armaganidis, B. Kadas, Ch. Roussos, D. Annane, M. C. Jars-Guincestre, F. Paraire, J. C. Raphaël, L. Lind, J. Mälstam, G. Skoog, J. -L. Teboul, J. Depret, N. Leger, D. Douguet, M. Zelter, A. Mercat, Ch. Richard, F. Saulnier, A. Durocher, G. Cadelis, F. Herengt, F. Wattel, B. Kugler, K. Träger, M. Holland, Th. Schricker, M. Georgieff, R. G. J. Westendorp, A. N. Roos, R. Simons, M. Frölich, A. E. Meinders, M. Lichtwarck-Aschoff, J. Aschenbrenner, G. Zimmermann, R. Senekowitsch, U. J. Pfeiffer, G. Blümel, A. T. Lovell, G. C. Hanson, P. J. Jensen, P. K. Andersen, C. Thøgersen, J. I. Poelaert, J. A. Everaert, D. P. Vogelaers, J. M. Decruyenaere, F. A. Colardyn, A. C. Timmins, M. Giles, C. J. Hinds, N. Maynard, D. Bihari, R. Mason, G. Baldock, I. McColl, D. Mathieu, R. Neviere, M. Fleyfel, J. Zaknun, L. Fridrich, D. Heute, S. Dyrk, A. Stoeger, M. Seyr, N. Mutz, G. Riccabona, J. Y. Lefrant, G. Aya, J. E. de la Coussaye, B. Bassoul, J. P. Auffray, J. J. Eledjam, S. Leucht, H. W. Kisch, R. Goller, J. P. Belot, B. Valtier, D. Mottin, D. Payen, A. Rubini, Del Monte, I. Attar, E. Catena, G. Rattazzi, G. L. Alati, P. Polisca, F. Turani, M. D. Pierri, L. Sommariva, Peppo A. de Penta, D. F. Colella, E. Zupancich, P. A. Gioffrè, L. Chiariello, A. Descorps-Declère, J. Hollande, M. Beaussier, O. Mimoz, J. Duranteau, A. Edouard, K. Samii, J. N. Drault, P. Marzollo, P. Sebastiano, M. Mariotti, P. Burnier, R. Chioléro, J. -J. Goy, Y. Schütz, H. Gombotz, H. Metzler, J. Plaza, J. Berger, W. F. List, D. C. Angus, N. M. Lidsky, L. M. Dotterweich, M. R. Pinsky, P. Evrard, B. de Ruyter, A. Dive, M. Gonzalez, L. Jacquet, E. Installé

Publikováno v: Intensive Care Medicine. 18:S173-S180

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca1b800503c7b84e65e23154ff7dd2c7
https://doi.org/10.1007/bf03216361